Clinical trial
Safety Study of Natalizumab in Combination With Glatiramer Acetate (GA)
NCT00097760 is registered in ClinicalTrials.gov with Biogen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety Study of Natalizumab in Combination With Glatiramer Acetate (GA)
- Lead sponsor
- Biogen
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2003
- Completion date
- March 31, 2004
- Enrollment
- 110 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.